AzTrials
AzTrials

Alcohol MisuseNCT07228923

Development and Evaluation of a Theory and Evidence-based Intervention to Reduce Hazardous Alcohol Consumption Among Treatment Seeking Smokers

A study testing Brief alcohol intervention in people with Alcohol Misuse, run by Centre for Addiction and Mental Health at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will evaluate the implementation of a fully automated, direct-to-patient digital alcohol intervention embedded within the STOP Program's patient portal. The STOP Program is a large-scale, population-based smoking cessation initiative operating in over 300 primary care settings across Ontario. Read more about this study

Who is it for?
Any age
Conditions the study is for
Alcohol Misuse
What is being tested?
Brief alcohol intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
77 participants
Where
1 siteCanada
Study dates
20 Nov 2025to 22 May 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • seeking treatment for smoking cessation
  • enrolling via the patient self-serve portal
  • AUDIT-10 score of 8 or higher

Who cannot join

  • none

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Centre for Addiction and Mental Health

    Toronto, Ontario, M6J1H4

Other trials in Canada

About this study

Official title: Evaluation of a Theory Informed Intervention to Reduce Hazardous Alcohol Consumption Among Treatment Seeking Smokers

This study will evaluate the implementation of a fully automated, direct-to-patient digital alcohol intervention embedded within the STOP Program's patient portal. The STOP Program is a large-scale, population-based smoking cessation initiative operating in over 300 primary care settings across Ontario. It provides free nicotine replacement therapy and behavioural support through a digital portal that facilitates patient self-enrollment and systematic data collection. As part of this study, patients who score ≥8 on the AUDIT-C will be offered the opportunity to view a brief intervention (BI). Those with an AUDIT-C score ≥10 will receive a cautionary message along with tailored content designed to help reduce hazardous drinking.

The intervention was developed based on a rapid review (PROSPERO: CRD42023445492) and a Delphi consensus process using the Behaviour Change Techniques Taxonomy V1. Key components include personalized feedback, normative comparisons, reflective prompts, and actionable behaviour change strategies. For patients scoring above a clinical threshold, additional messaging encourages caution regarding abrupt cessation and suggests consulting a healthcare provider.

Our primary outcome is acceptance of the new online resource.

Conditions
Alcohol Misuse
Being tested
Brief alcohol intervention
Keywords
Smoking Cessation, Alcohol, Brief Intervention, SBIRT
Medical subject headings
Smoking Cessation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Brief alcohol interventionBehavioural

    The intervention is a prompt that that appears as an alert message in the patient portal, recommending the alcohol intervention.

Study groups in NCT07228923
Study groupRoleWhat they receive
Patient Portal PromptExperimentalBrief Alcohol Intervention
Receives: Behavioral: Brief alcohol intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. overall acceptance rate

    Measured: Immediate: acceptance of offered intervention during baseline survey data collection (following eligibility determination in same survey).

Secondary outcomes (1)
  1. Provider-initiated discussion of alcohol use at the first clinical treatment visit

    Provider-initiated discussion of alcohol use at the first clinical treatment visit. Following self-enrolment, providers reviewed participant questionnaires prior to or during the first visit and were asked to record whether they had discussed alcohol use with the participant. This outcome is captured via the portal data-collection system.

    Measured: Assessed at the first clinical visit within 2 months after baseline survey completion.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Nov 2025
  2. Study start20 Nov 2025
  3. Primary completion22 May 2026
  4. Study completion22 May 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
77 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07228923
Sponsor's protocol ID
DCP-196026
Status last verified
Nov 2025
First submitted
13 Nov 2025
Last updated
11 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Brief alcohol intervention in people with Alcohol Misuse, run by Centre for Addiction and Mental Health at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

overall acceptance rate (time frame: Immediate: acceptance of offered intervention during baseline survey data collection (following eligibility determination in same survey).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in